ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentLausanneAC Immune SA
AC Immune SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of AC Immune SA is the development of therapeutics for neurodegenerative diseases, particularly Alzheimer's disease, and other central nervous system disorders. The company focuses on researching, developing and commercializing innovative medicines and therapies in collaboration with leading pharmaceutical and biotechnology companies, academic institutions and patient organizations.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.2/5

AC Immune SA

✓ Offered6
Precision medicine for neurodegenerative diseases
Precision medicine approaches for Alzheimer’s, Parkinson’s and selected rare neurodegenerative diseases; integrated diagnostics and therapeutics to monitor disease-specific proteinopathies and select the appropriate treatment.
Antibody and active immunotherapies
Active immunotherapies and monoclonal antibodies against misfolded proteins such as Tau, amyloid-beta, alpha-synuclein and TDP-43; developed for Alzheimer’s, Parkinson’s and NeuroOrphan indications.
Small-molecule aggregation inhibitors
Small-molecule agents to inhibit intracellular protein aggregates, in particular Tau and alpha-synuclein aggregation, with candidates for Alzheimer’s, Parkinson’s and neuroinflammatory targets.
Diagnostic PET tracers
PET imaging tracers for reliable detection of pathological protein deposits, in particular Tau and alpha-synuclein targets, for early diagnosis and biomarker-based study planning.
NLRP3 inhibitors for neuroinflammation
Small molecules and antibodies to inhibit the NLRP3 inflammasome pathway in CNS and non-CNS indications, with a focus on neuroinflammatory disease mechanisms.
Research and development of therapeutics and diagnostics
Parallel development of therapeutics and diagnostics in clinical and preclinical pipelines, including active immunotherapies, antibodies, small molecules and diagnostic candidates.
Trust & reputation

ranQ Trust Score of AC Immune SA: 4.2 out of 5.0

Trust Score4.2/ 5.0

Very high

x

Data basis 96% · As of October 2026

AC Immune SA scores 56.6 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.70.824%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.27.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.50.08%
AC Immune SA scores 95.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.96.07%
AC Immune SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
AC Immune SA scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

AC Immune SA reaches a ranQ Trust Score of 4.2 out of 5.0 — rated «Very high». The rating draws, among other things, on 5.0 out of 5 stars from 2 customer reviews. The data basis is 96%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 2 reviews across all connected sources

Sources
GGoogle52
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once AC Immune SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

AC Immune SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank AC Immune SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of AC Immune SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

EPFL
1015 Lausanne

At a glance

Legal form
Corporation
UID
CHE-109.878.825
Founded
2003 · 23 years
Last commercial register change
July 15, 2026
Employees
101 to 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SS
    Saphetor SA
    Lausanne
    NB
    ND BioSciences SA
    Epalinges
    ES
    Exciva Switzerland SA
    Epalinges
    AT
    ADC Therapeutics SA
    Epalinges
    NA
    Novigenix AI SA
    Epalinges
    AS
    ABBGen Sàrl
    Lausanne
    PS
    Pharmotech SA
    Eysins
    SP
    Swiss Prime Lab SA
    Lausanne